This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The surge in MASH cases stresses the need for early diagnosis, timely intervention and precise, reliable methodologies in clinicaltrials to evaluate new therapies effectively. Read on to gain insights from Medpace experts about advancements in imaging, histology and innovative techniques for MASH clinicaltrials.
This prestigious acknowledgment places Cloudbyz among the top-performing companies globally, known for delivering scalable and intuitive CTMS solutions that empower clinical research teams. Our mission is to enable faster, more efficient trials, ultimately supporting the delivery of life-saving therapies.”
This week, were celebrating a significant milestone: the release of our 200th episode of the Xtalks LifeScience Podcast ! We’re excited to continue our journey by bringing you more in-depth conversations with industry leaders, highlighting the innovations and trends that shape the future of lifesciences.
In the lifesciences sector, one country is significantly outstripping others for FDI. Data shows that almost 40% of all lifesciences subsidiaries are located in the US. After all, around a third of the world’s leading lifesciences corporations have their headquarters in the country. Industry clusters.
In clinical research, diversity is more than a prerequisite for a successful drug — it’s a critical component that enhances the validity and applicability of clinicaltrial outcomes. Diversity Action Plans have now moved from being a “nice-to-have” to a “must-have” in clinicaltrial designs.
GSK has entered a strategic partnership with Wave LifeSciences to progress the discovery and development of oligonucleotide therapies for new genetic targets. On completion of the first-in-patient clinicaltrial by Wave, GSK will be in charge of the development and marketing works.
Clinicaltrials have been steadily leaving the UK for years. of patients recruited to global trials were from the UK. Thats not to say we dont still have some clout (the UK ranks fourth globally for Phase II trials ), but the trending outflow needs to be addressed. In 2021, just 2.2%
A successful lifescience webinar engages the audience in a unique manner, drives the right kind of traffic and provides genuine value for attendees. Here are 5 trending lifescience webinar topics that have been resonating well with our audiences. Decentralized ClinicalTrials, Hybrid Trials & Virtual Trials .
The lifescience industry is constantly evolving, making it difficult to stay ahead of the curve. Digital transformation is burgeoning and we aim to cover some of the dominant emerging technologies that are currently running the lifescience industry by storm.
Lifescience podcasts have emerged as an invaluable tool for building connections with audiences in the digital era. Furthermore, we’ll explore the unique advertising opportunities that this platform offers, positioning brands at the forefront of the lifescience industry. The result?
Lifescience consulting can be a rewarding career and the job outlook is promising for the future. . Perhaps you have heard of lifescience consulting jobs but do not exactly know what type of work is involved, or the education and experience needed to become a lifescience consultant. Job Description.
As we step into 2024, the lifesciences continue to evolve at an unprecedented pace, driven by technological innovation, a deeper understanding of human biology and the application of new technologies in areas like drug development and health wearables. These companies are at various stages of research and clinicaltrials.
In the dynamic world of lifesciences, where innovation is paramount, the integration of cutting-edge technologies is crucial for accelerating clinical operations and driving breakthroughs in healthcare. Salesforce’s recent announcement of its LifeSciences Cloud marks a significant stride towards this goal.
Pharmaceutical companies often struggle to actively involve patients in the design phase of clinicaltrials but doing so can have huge benefits for the sustainability and success of research. Gaining patient input on marketing and recruitment materials. How the NIHR’s Patient Engagement in Clinical Development service can help.
Xtalks is proud to announce the launch of the Xtalks LifeScience podcast. Subscribe to the Xtalks LifeScience Podcast to never miss a new episode. Fresh Conversations About LifeScience Topics. Sarah is passionate about science communication and journalistic integrity.
Many companies in the lifesciences industry are slow to adopt new technologies. Running clinicaltrials costs a lot of money! Many clinicaltrials fail. For example, it can be difficult to recruit patients or they may drop out during the trial. What is meant by automating clinicaltrials?
Sheila Rocchio highlights four key areas lifesciences must improve on as an industry to drive real change in how clinicaltrials are conducted. This is definitely a time for the lifesciences industry to be proud of our accomplishments. The future of clinicaltrials after the pandemic appeared first on.
BlueRock Therapeutics, a subsidiary of Bayer AG, is making waves in the treatment of Parkinsons disease by advancing its investigational cell therapy, bemdaneprocel, to a Phase III clinicaltrial. In the Phase I trial, 12 participants received the therapy and were observed for two years. As of 2023, there were approximately 2.7
From enabling patient choice during clinicaltrials to strengthening vital partnerships across the quality ecosystem, connected data will become the lifeblood that enables lifesciences teams to collaborate efficiently and effectively in 2023. Simplicity and technology intersect to streamline drug development.
These workspaces mimic their physical counterparts in all ways but are superior in several factors that are leading to explosive growth in this market. This provides invaluable usability feedback and, most importantly, makes sure that new features are embedded in the VDR platform and tested thoroughly before being released to the market.
Getting a drug to market used to be a relatively simple and straightforward affair. Whether it’s for a treatment for a chronic ambulatory condition, precision medicine or cell and gene therapy, there is a massive uptick in clinicaltrial complexity. That’s just not the case anymore.
As advancements in research forge ahead, it is imperative to ensure patients are informed about and can access potentially life-saving clinicaltrials. Tell us about your recent work regarding colorectal cancer clinicaltrials. How does the Colorectal Cancer Alliance support clinicaltrials for colorectal cancer?
The COVID-19 pandemic has catalysed significant changes in the way pharma develops drugs, particularly in the clinicaltrial space. Hybrid or decentralised clinicaltrials (DCTs) have gained traction as technology, infrastructure and knowledge have evolved to support their use. Source: Izmailova et al, 2017.
At the beginning of September, Velocity Clinical Research topped Business North Carolina ’s 2024 Fast 40 list. It was our third time receiving the award, which recognizes the fastest-growing mid-market businesses in the state. For a clinicaltrials organization to achieve this level of scale is notable.
Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinicaltrials. Can the combined potential of new AI technologies and real-world patient data hold the key to overcoming the challenges in clinicaltrial design that have historically led to trial failure?
The Foundation for the National Institutes of Health (FNIH) announced this week that the Accelerating Medicines Partnership Bespoke Gene Therapy Consortium (AMP BGTC) has selected eight rare diseases for its clinicaltrial portfolio.
Jupiter Neurosciences, a clinical-stage pharma company specializing in neuroinflammation, made its public market debut with an initial public offering (IPO) on the Nasdaq Capital Market under the symbol “JUNS.” ” The company priced 2,750,000 shares of common stock at $4.00
If the past year is anything to go by, then 2022 will also be a year marked by continued innovations in the lifesciences. Here is a look at some lifescience trends to expect in the coming year, including key themes and topics in the pharmaceutical, biotechnology and medical device industries to keep an eye out for in 2022.
In the early stages of drug development, it is logical to focus on the economic and clinical aspects of candidate identification: Is there enough of a market? Could this candidate demonstrate clinical efficacy? The post Making new product planning for lifescience more effective with human-centred design appeared first on.
In this interview, Xtalks spoke with experts from eClinical Solutions , Katrina Rice, Chief Delivery Officer, Data Services; and Diane Lacroix, Vice President, Clinical Data Management, about clinical data management for modern day digital clinicaltrials. Clinical Data Pipeline for Data Review and Analyses.
In an email to Pharmaceutical Technology , an NHSBT spokesperson said the centre will “support early phase clinicaltrials and preclinical work, providing a route to eventual commercial scale production”. In the past, researchers have often had to seek help from outside the UK, thus delaying clinicaltrials and patient access.
This is relevant for clinicaltrials as more regulators require evidence of efficacy in comparison to the standard of care, which is likely to be one of the blockbuster products. Several oncology products now have “blockbuster” status where sales exceed $1 billion annually. Herceptin (Trastuzumab) and Mabthera (Rituximab).
Josh Sackman, president and co-founder of AppliedVR, and Web Sun, president and co-founder of Komodo Health, relay how their newly formed collaboration reshapes the clinicaltrial process by using data, helping to cut costs and allowing for evaluation of broader patient populations. .
mg), underperformed in its latest clinicaltrial, leading to a dip in the companys share price. In response to the trial outcomes, Novos shares declined by approximately 8% this week. Novo shared the latest data from the Phase III REDEFINE 2 trial evaluating the drug in overweight or obese patients with type 2 diabetes.
Dudley Tabakin, CEO of VivoSense, describes how this financing is set to accelerate the development of novel digital biomarkers and improve digital clinical outcome assessments. The wearable market was starting to proliferate, and people were starting to ask questions. How can this data be incorporated into clinicaltrials?”.
Abel Archundia discusses how COVID-19 has highlighted the importance of securing clinicaltrials against cyber threats. However, data-intensive, decentralised clinicaltrials also present a major risk to healthcare participants through cybercrime and data privacy vulnerability. About the author.
Pharma companies face many challenges when involving patients in the design of clinicaltrials – but doing so can have huge benefits further down the line, improving the sustainability and quality of research. Involving patients in discussions.
Today, world-leading generative artificial intelligence (AI) company for lifesciences, Yseop, is celebrating its involvement in more than 150 clinicaltrials with pharma giants around the world.
JSR LifeSciences’ business unit Similis Bio is planning to collaborate with Novel351k for the development of three biosimilar programmes targeting cancer and autoimmune diseases. This will lead to pharmacokinetics/pharmacodynamic clinicaltrials. This will lead to pharmacokinetics/pharmacodynamic clinicaltrials.
Xtalks is taking a look at some of the major stories and innovations of the year in the lifesciences, many of which were driven by new, emerging and improved technologies. The year 2021 was all about continuing innovations in the lifesciences. LifeScience Innovations: Malaria and Influenza Vaccines.
Orphan drug development poses many challenges that are unique to rare diseases, including recruitment in small patient populations, variable progression with heterogenous clinical manifestations and limited understanding of disease progression and natural history.
Pharma has a great opportunity ahead of it when it comes to conducting representative clinicaltrials. The processes used are now seeing huge infrastructure commitments, in order to cement their place in the development of future products and trials. But there are three important steps which could mitigate the impact.
Cloudbyz Earns Dual Recognition in Everest Groups 2024 PEAK Matrix for CTMS and EDC Solutions Driving Innovation in ClinicalTrial Management Cloudbyz is proud to announce its dual recognition in Everest Groups 2024 PEAK Matrix assessments for both ClinicalTrial Management System (CTMS) and Electronic Data Capture (EDC) solutions.
The deal will see Polyplus join the German lifescience group’s portfolio allowing the latter to leverage expertise in transfection reagents and plasmid DNA for gene therapy. In the dynamically growing market for cell and gene therapies, viral vectors are needed to deliver the genes of interest into cells.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content